Clinical Trial Update: Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating romiplostim to treat low platelets after chemotherapy and autologous hematopoietic cell transplantation in people with blood cancers; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma, Hodgkin Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2024-02-14